Ulstrom, R.A. and Eisenklam, E.: The enterohepatic shunting of bilirubin in the newborn infant. I. Use of oral activated charcoal to reduce normal serum bilirtibin values. J. Pediat.65: 27, 1964.
2.
Lester, R., Hammaker, L. and Schmid, R.: A new therapeutic approach to unconjugated hyperbilirubinemia. Lancet2: 1257, 1962.
3.
Poland, R.L. and Odell, G.B.: Physiologic jaundice: the entero-hepatic circulation of bilirubin. New Eng. J. Med.284: 1, 1971.
4.
Ertel, I.J. and Newton, W.A., Jr.: Therapy in congenital hyperbilirubinemia: phenobarbital and diethylnicotinamidePediatrics44: 43, 1969.
5.
Kintzel, H.W. , Hinckel, G.K. and Schwarze, R.: The decrease in the serum bilirubin level in premature infants by orotic acid. Acta Pediat. Scand.60: 1, 1971.
6.
Catz, C. and Yaffe, S.J.: Barbiturate enhancement of bilirubin conjugation and excretion in young and adult animals. Pediat. Res.2: 361, 1968.
7.
Ramboer, C., Thompson, R.P.H. and Williams, R.: Controlled trials of phenobarbitone therapy in neonatal jaundice. Lancet1: 966, 1969.
8.
Vest, M., Signer, E., Weisser, K. and Olafsson, A.: A double-blind study of the effect of phenobarbitone on neonatal hyperbilirubinemia and frequency of exchange transfusion. Acta Paediat. Scand.59: 681, 1970.
9.
Trolle, D.: Decrease of total serum bilirubin concentration in newborn infants after phenobarbi. tone treatment. Lancet2: 705, 1968.
10.
McMullin, G.P. , Hayes, M.F. and Arora, S.C.: Phenobarbitone in rhesus hemolytic disease: a controlled trial. Ibid.2: 949, 1970.
11.
Thaler, M.M. : Substrate induced conjugation of bilirubin in genetically deficient newborn rats. Science170: 555, 1970.
12.
Bakken, A.F. : Effects of unconjugated bilirubin UDP glucuronyl transferase activity in liver of newborn rats. Pediat. Res.3: 205, 1969.
13.
Stern, L., Khanna, N.N., Levy, G. and Yaffe, S.J.: Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in newborns. Amer. J. Dis. Child.120: 26, 1970.
14.
Kuntzman, R.G. : In Proc. Conf. Pediat. Pharmacology , Washington, D. C.1967, p. 29.
15.
Mountain, K.R. , Hirsh, J. and Callus, A.S.: Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet1: 265, 1970.
16.
Richens, A. and Rowe, D.J.A.: Disturbance of calcium metabolism by anticonvulsant drugs. Brit. Med. J4: 65, 1970.
17.
Oswald, I.: Human brain protein, drugs and dreams. Nature223: 893, 1969.
